Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WASH complex subunit 5 (WASHC5), also known as Strumpellin or KIAA0196, is a ubiquitously expressed protein that serves as a core component of the WASH complex, which acts as a nucleation-promoting factor (NPF) for actin polymerization at endosome surfaces[1][3][7]. Through recruitment and activation of the Arp2/3 complex, it is essential for actin-mediated endosome fission, sorting, and intracellular trafficking of cargos[3][7]. Mutations in WASHC5 cause hereditary spastic paraplegia type 8 and 3C syndrome (Ritscher-Schinzel syndrome), highlighting its role in both neurodegenerative and developmental disorders[1][3][4]. WASHC5 is not currently recognized as a direct therapeutic drug target, nor are there drugs known to specifically target this protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WASH complex subunit 5 (WASHC5).